PREVALENCE OF MULTIDRUG RESISTANT E. coli AND ROLE OF Β-LACTAMASE | ||||
| Journal of Agricultural Chemistry and Biotechnology | ||||
| Article 5, Volume 7, Issue 3, March 2016, Page 85-88 PDF (415.44 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/jacb.2016.40783 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
| M. Abou Dobara1; Heba Al-Degla2; A. Elnagdy1 | ||||
| 1Botany Department, Faculty of science, Damietta University, Egypt | ||||
| 2Microbiology Department, Faculty of Medicine, Mansura University, Egypt | ||||
| Abstract | ||||
| Urinary tract infection (UTI) is one of the most common bacterial infections and Gram negative bacteria are among the most prevalent bacteria detected from UTI patients. E. coli is the most common organism causing both community as well as hospital acquired UTI. The high incidence of UTIs in the general population, the potential for complications, and the associated costs of treatments emphasize the importance of appropriate antibiotic therapy. The resistance rates of uropathogenic E. coli to various antibiotics have been reported as beta-lactams, trimoxazole, quinolones, gentamicin, amikacin, cefuroxime, nalidixic acid | ||||
| Keywords | ||||
| Urinary tract infection; E. coli; β-lactamase; Extended-spectrum β-lactamase | ||||
|
Statistics Article View: 93 PDF Download: 270 |
||||
